Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000232568 | SCV000282788 | pathogenic | Familial adenomatous polyposis 1 | 2016-01-06 | criteria provided, single submitter | clinical testing | This sequence change inserts 1 nucleotide in exon 6 of the APC mRNA (c.595dupG), causing a frameshift at codon 199. This creates a premature translational stop signal (p.Ala199Glyfs*53) and is expected to result in an absent or disrupted protein product. Truncating variants in APC are known to be pathogenic. This particular truncation has been reported in the literature in an individual affected with familial adenomatous polyposis (FAP) with extracolonic phenotypes (PMID: 9067764). This variant is also referred to in the literature as 595insG. For these reasons, this variant has been classified as Pathogenic. |
Invitae | RCV003535631 | SCV002152382 | pathogenic | Familial adenomatous polyposis 1 | 2016-01-06 | criteria provided, single submitter | clinical testing | Truncating variants in APC are known to be pathogenic. This particular truncation has been reported in the literature in an individual affected with familial adenomatous polyposis (FAP) with extracolonic phenotypes (PMID: 9067764). This variant is also referred to in the literature as 595insG. For these reasons, this variant has been classified as Pathogenic. This sequence change inserts 1 nucleotide in exon 6 of the APC mRNA (c.595dupG), causing a frameshift at codon 199. This creates a premature translational stop signal (p.Ala199Glyfs*53) and is expected to result in an absent or disrupted protein product. |